Yonsei University College of Medicine Researchers Further Understanding of Melanoma (PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma)

Media coverage

• Title	Yonsei University College of Medicine Researchers Further Understanding of Melanoma (PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma)
  Media name/outlet	Genomics & Genetics Daily
  Country/Territory	United States
  Date	4/24/26
  Persons	Min-Hyun Kim